Skip to main navigation menu Skip to main content Skip to site footer

The natural history of fungal sensitization in asthma

La historia natural de la sensibilización fúngica en el asma




Section
Presentación de casos

How to Cite
The natural history of fungal sensitization in asthma.
rev. colomb. neumol. [Internet]. 2015 Jul. 20 [cited 2024 Nov. 21];27(3). Disponible en: https://doi.org/10.30789/rcneumologia.v27.n3.2015.87

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Luisa Fernanda Manrique, MD., MSc.
    Claudia Patricia Zuluaga, MD.

      Luisa Fernanda Manrique, MD., MSc.,

      Internista, Neumóloga, Hospital General de Medellín y CEMDE S.A. Medellín, Colombia.

      Claudia Patricia Zuluaga, MD.,

      Radióloga, Hospital Militar de Medellín. Hernán Ocazionez y Cia S.A, Clínica Medellín de Occidente. Medellín, Colombia.

      Severe asthma with fungal sensitization (SAFS) is part of the continuum of diseases that begins with asthma and ends with allergic bronchopulmonary aspergillosis. These conditions often run underdiagnosed, and can be associated with irreversible pulmonary damage such as bronchiectasis and pulmonary fibrosis. New diagnostic criteria have been recently described, which are expected to aid in earlier management and to benefit clinical investigation.

      Article visits 844 | PDF visits 1010


      Downloads

      Download data is not yet available.
      1. Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Resp. 2011;11:403–13.
      2. Agarwal R, Chakrabarti A, Shah A, Gupta D, et al. Allergic broncopulmonary aspergilosis: review of the literature and proposal of new diagnostic and classification criteria. Clin Exp Allerg. 2013;43:850–73.
      3. Agarwal R, Aggarwal N, Gupta D, Jindal K. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13:936–44.
      4. Patterson K, Strek Mary E. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146 (5):1358-68.
      5. Hogan C, Denning D. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Sem Resp Crit Care Med. 2011;32(6):682- 92.
      6. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009;135:805-26.
      7. Greenberg P. When to suspect and work up allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Inmunol. 2013;111:1–4.
      8. Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol. 2012;4:141-50.
      9. Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66:679–85.
      10. Agarwal R, Hhan A, Gupta D, Aggarwal A, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One. 2010;12:e15346.
      11. Franquet T, Müller NL, Gimenez A, Gumbe P, de la Torre J, Bagué S. Spectrum of pulmonary aspergillosis: histolo-gic, clinical, and radiologic findings. RadioGraphics. 2001; 21:825–37.
      12. Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax. 1994;49:586-89.
      13. Patterson R, Greenberg PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roetgenographic. Arch Intern Med. 1986;146(5):916-18.
      14. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002;110: 685-92.
      15. Mahdavinia M, Grammer LC. Management of allergic bronchopulmonary aspergillosis: a review and update. Ther Adv Respir Dis. 2012;6:173-87.
      16. Hamilton Rg, Marcotte GV, Saini SS. Inmunological methods for quatifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy. J Immunol Methods. 2005;303(1-2):81–91.
      17. Agarwal R, Khan A, Aggarwal AN, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary apergillosis. J Infect Public Health. 2011;4:235-43.
      18. Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2015;4:11.
      Sistema OJS 3.4.0.7 - Metabiblioteca |